LINC01352 Gene

Name long intergenic non-protein coding RNA 1352
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Long non‐coding RNA LINC01352 has emerged as a multifunctional regulatory molecule with cancer‐specific roles. In lung squamous cell carcinoma, LINC01352 is part of a competitive endogenous RNA (ceRNA) network, where it interacts with miR‐2278 along with several other lncRNAs to serve as a potential diagnostic and prognostic biomarker panel."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In lung adenocarcinoma, LINC01352 has been identified among a set of 12 ferroptosis‐related lncRNAs that form a robust risk prediction model, highlighting its relevance as a prognostic indicator in this heterogeneous malignancy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In the context of HBV‐related hepatocellular carcinoma, LINC01352 functions as a tumor suppressor; its expression is markedly downregulated by the HBV X protein (HBx) via formation of a complex with estrogen receptor α. This downregulation diminishes LINC01352’s role as an endogenous sponge for miR‐135b, ultimately reducing adenomatous polyposis coli (APC) levels and triggering activation of the Wnt/β‐catenin pathway, thereby promoting tumor growth and metastasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Furthermore, broader analyses of lncRNA‐based prognostic signatures, including those incorporating LINC01352, have underscored the utility of these biomarkers in refining risk stratification in cancers such as endometrial carcinoma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Tao Zhang, Lei Deng, Ying Ji, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel long noncoding RNA (lncRNA) panel as biomarkers for prognosis in lung squamous cell carcinoma via competitive endogenous RNA (ceRNA) network analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Cancer Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21037/tcr-20-2410"}], "href": "https://doi.org/10.21037/tcr-20-2410"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35116269"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35116269"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Lu Lu, Le-Ping Liu, Qiang-Qiang Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fonc.2021.675545"}], "href": "https://doi.org/10.3389/fonc.2021.675545"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34249715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34249715"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Pinbo Huang, Qiaodong Xu, Yongcong Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-020-1254-z"}], "href": "https://doi.org/10.1038/s41388-020-1254-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32157216"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32157216"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hong Tang, Zhixi Wu, Yuan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2019.4944"}], "href": "https://doi.org/10.1089/dna.2019.4944"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31539276"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31539276"}]}]}]}
NCBI Gene ID 101929730
API
Download Associations
Predicted Functions View LINC01352's ARCHS4 Predicted Functions.
Co-expressed Genes View LINC01352's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View LINC01352's ARCHS4 Predicted Functions.

Functional Associations

LINC01352 has 5 functional associations with biological entities spanning 1 categories (gene, protein or microRNA) extracted from 1 datasets.

Click the + buttons to view associations for LINC01352 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of LINC01352 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.